Compounds > carvedilol

carvedilol and D-fructopyranose

carvedilol has been researched along with D-fructopyranose in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Bertera, F; Buontempo, F; Chiappetta, D; Di Verniero, CA; Höcht, C; Mayer, MA; Polizio, AH; Taira, CA1
Abdulla, MH; Abdullah, NA; Johns, EJ; Sattar, MA1
Ibrahim, IAAE; Mahmoud, AAA; Mahmoud, MF; Mohammed, SG1
Ibrahim, IAAE; Ibrahim, WS; Mahmoud, AAA; Mahmoud, MF1
Ibrahim, IAAE; Mahmoud, AAA; Mahmoud, MF; Rezk, AM1
Ahmed, HMS; Ibrahim, IAAE; Ibrahim, WS; Mahmoud, AAA; Mahmoud, MF; Mohamed, SG; Rezk, AM1

Other Studies

6 other study(ies) available for carvedilol and D-fructopyranose

ArticleYear
Pharmacokinetic and pharmacodynamic properties of carvedilol in fructose hypertensive rats.
    Xenobiotica; the fate of foreign compounds in biological systems, 2012, Volume: 42, Issue:2

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Fructose; Heart Rate; Hypertension; Male; Propanolamines; Rats; Rats, Sprague-Dawley

2012
The effect of losartan and carvedilol on renal haemodynamics and altered metabolism in fructose-fed Sprague-Dawley rats.
    Journal of physiology and biochemistry, 2012, Volume: 68, Issue:3

    Topics: Angiotensin II; Animals; Body Weight; Carbazoles; Carvedilol; Fructose; Glucose Tolerance Test; Hemodynamics; Insulin Resistance; Kidney; Losartan; Male; Norepinephrine; Phenylephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents

2012
Carvedilol protects against hepatic ischemia/reperfusion injury in high-fructose/high-fat diet-fed mice: Role of G protein-coupled receptor kinase 2 and 5.
    Toxicology and applied pharmacology, 2019, 11-01, Volume: 382

    Topics: Animals; Carvedilol; Diet, High-Fat; Fructose; G-Protein-Coupled Receptor Kinase 2; G-Protein-Coupled Receptor Kinase 5; Liver Diseases; Male; Mice; Protective Agents; Reperfusion Injury; Vasodilator Agents

2019
Carvedilol Diminishes Cardiac Remodeling Induced by High-Fructose/High-Fat Diet in Mice via Enhancing Cardiac β-Arrestin2 Signaling.
    Journal of cardiovascular pharmacology and therapeutics, 2020, Volume: 25, Issue:4

    Topics: Animals; beta-Arrestin 2; Cardiomegaly; Carvedilol; Cytokines; Diet, High-Fat; Dietary Sugars; Disease Models, Animal; Fibrosis; Fructose; Insulin Resistance; Male; Mice; Myocytes, Cardiac; Phosphatidylinositol 4,5-Diphosphate; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling

2020
Quercetin and lithium chloride potentiate the protective effects of carvedilol against renal ischemia-reperfusion injury in high-fructose, high-fat diet-fed Swiss albino mice independent of renal lipid signaling.
    Chemico-biological interactions, 2021, Jan-05, Volume: 333

    Topics: Animals; Apoptosis; Carvedilol; Cytoprotection; Diet, High-Fat; Drug Synergism; Fructose; Kidney; Lithium Chloride; Male; Malondialdehyde; Mice; Oxidative Stress; Quercetin; Reperfusion Injury; Signal Transduction

2021
Acute and chronic metabolic effects of carvedilol in high-fructose, high-fat diet-fed mice: implication of β-arrestin2 pathway.
    Canadian journal of physiology and pharmacology, 2022, Volume: 100, Issue:1

    Topics: Animals; beta-Arrestin 2; Carvedilol; Diet, High-Fat; Dietary Carbohydrates; Diglycerides; Dyslipidemias; Fructose; Glucose; Homeostasis; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Proto-Oncogene Proteins c-akt; Signal Transduction; Up-Regulation

2022